
- BioPharm International-11-01-2017
- Volume 30
- Issue 11
Temperature-Controlled Shipping Solution
The Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is compliant with good distribution practices and comes in three models.
Almac Group has expanded availability of the Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, to the United States as part of the company’s end-to-end, global supply chain management solution. Originally released in Europe, the service is compliant with good distribution practices and comes in three models: protected, optimized, and dynamic.
The protected model is qualified for up to 96 hours against thermal challenges by the International Safe Transit Association and is available in -15 °C to -25 °C, +2 °C to +8 °C, and +15 °C to +25 °C temperature ranges. The optimized model is also qualified for up to 96 hours of protection, eliminates temperature excursions, is suited for reuse with no shippers left at the clinical site, and requires no disposal. The dynamic model features upgraded operational processing capacity and flexibility, and uses a phase-change material to offer increased thermal protection. It can be immediately placed into appropriate storage at each point of packing and in-transit. For this model, Almac has the ability to perform a year-round pack out of clinical shipments.
Articles in this issue
almost 8 years ago
Connector Integrity in Single-Use Biomanufacturing Systemsalmost 8 years ago
FDA Overhauls Inspection Process and Field Operationsalmost 8 years ago
ADC Development Robust Despite Lackluster Performancealmost 8 years ago
Change Control for Standard Operating Proceduresalmost 8 years ago
CDMO Acquisitions Build Strategic Supplier Basealmost 8 years ago
Pump Head for Shear-Sensitive Pumpingalmost 8 years ago
Dip-Molded Plastisol Y Connectorsalmost 8 years ago
Analytical Data System Updatealmost 8 years ago
Evaluating Surface Cleanliness Using a Risk-Based Approachalmost 8 years ago
Awards Recognize Bio/Pharma Industry ContributionsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.